HealthCor fund distributes 4.6M Heartflow shares

Heartflow, Inc. insider HealthCor Partners Management LP reported a restructuring-type transaction involving 4,615,542 shares of Heartflow common stock.

Accepted by SEC EDGAR 03/26/2026 - 01:04 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Heartflow, Inc. insider HealthCor Partners Management LP reported a restructuring-type transaction involving 4,615,542 shares of Heartflow common stock. On March 24, 2026, these shares, held indirectly through HCPCIV I, LLC, were distributed to fund investors, and the reporting person’s indirect holdings in this block dropped to zero. This was classified as an “other” transaction rather than an open-market purchase or sale.

Insider Trade Summary

Other: 4,615,542 shares

Other 1 txn

Insider HealthCor Partners Management LP

Role Director

Type	Security	Shares	Price	Value
Other	COMMON STOCK	4,615,542	$0.00	$0.00

Holdings After Transaction: COMMON STOCK — 0 shares (Indirect, By HCPCIV I, LLC)

Footnotes (1)

1. F1. EACH SHARE OF COMMON STOCK WAS DISTRIBUTED TO FUND INVESTORS.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did HealthCor Partners report in its Heartflow (HTFL) Form 4?

HealthCor Partners Management LP reported an “other” transaction involving 4,615,542 shares of Heartflow common stock. The shares were distributed from an affiliated entity to fund investors, reflecting a restructuring of how those shares are held rather than a market trade.

How many Heartflow (HTFL) shares were affected in this HealthCor transaction?

The filing shows 4,615,542 shares of Heartflow common stock were involved. These shares were previously held indirectly through HCPCIV I, LLC and were distributed to fund investors, according to the footnote describing the transaction as a distribution rather than a typical buy or sell.

Was HealthCor’s Heartflow (HTFL) Form 4 a stock purchase or sale?

The Form 4 was not a standard purchase or sale. It used transaction code J, described as “other acquisition or disposition,” and the footnote explains each share was distributed to fund investors, indicating an internal restructuring instead of an open-market trade.

What does the footnote in HealthCor’s Heartflow (HTFL) Form 4 explain?

The footnote states that each share of Heartflow common stock was distributed to fund investors. This clarifies that the 4,615,542-share movement reflects a distribution from an affiliated entity, HCPCIV I, LLC, rather than a typical cash transaction on the open market.

How did this Form 4 change HealthCor’s indirect Heartflow (HTFL) holdings?

After the transaction, the total shares shown as indirectly held following the event were zero. This indicates the reporting person no longer indirectly holds the 4,615,542 shares that were previously attributed through HCPCIV I, LLC and were distributed to the fund’s investors.

What does transaction code J mean for the Heartflow (HTFL) filing?

Transaction code J on this Heartflow Form 4 indicates an “other acquisition or disposition” rather than a straightforward buy or sell. Here, it corresponds to a redistribution of 4,615,542 shares to fund investors, consistent with a restructuring of ownership within the investment structure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HealthCor Partners Management LP

(Last) (First) (Middle)

186 SEVEN FARMS DRIVE, SUITE F-371

(Street)

DANIEL ISLAND SOUTH CAROLINA 29492

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Heartflow, Inc. [ HTFL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/07/2025

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
COMMON STOCK	03/24/2026		J(1)		4,615,542	D	(1)	0	I	By HCPCIV I, LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. EACH SHARE OF COMMON STOCK WAS DISTRIBUTED TO FUND INVESTORS.

	ELIZABETH M. LILLEY	03/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)